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ABSTRACT 
 
Calcification of the human lens has been described in senile cataracts and in young patients with 
congenital cataract or chronic uveitis. Lens calcification is also a major complication of cataract 
surgery and plays a role in the opacification of intraocular lenses. A cell-mediated process has been 
suggested in the background of lens calcification, but so far the exact mechanism remained 
unexplored. Lens calcification shares remarkable similarities with vascular calcification; in both 
pathological processes hydroxyapatite accumulates in the soft tissue. Vascular calcification is a 
regulated, cell-mediated process in which vascular cells undergo osteogenic differentiation. Our 
objective was to investigate whether human lens epithelial cells (HuLECs) can undergo osteogenic 
transition in vitro, and whether this process contributes to lens calcification. We used inorganic 
phosphate (Pi) and Ca to stimulate osteogenic differentiation of HuLECs. Osteogenic stimuli (2.5 
mmol/L Pi and 1.2 mmol/L Ca) induced extracellular matrix mineralization and Ca deposition in 
HuLECs with the critical involvement of active Pi uptake. Osteogenic stimuli almost doubled mRNA 
expressions of osteo-/chondrogenic transcription factors Runx2 and Sox9, which was accompanied by 
a 1.9-fold increase in Runx2 and a 5.5-fold increase in Sox9 protein expressions. Osteogenic stimuli 
induced mRNA and protein expressions of alkaline phosphatase and osteocalcin in HuLEC. Ca 
content was higher in human cataractous lenses, compared to non-cataractous controls (n=10). 
Osteocalcin, an osteoblast-specific protein, was expressed in 2 out of 10 cataractous lenses. We 
conclude that osteogenic stimuli induce osteogenic differentiation of HuLECs and propose that this 
mechanism might play a role in lens calcification.    
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1. INTRODUCTION 
According to the Global Eye Health Statistics, at least 25 million eyes develop decreased visual acuity 
due to cataract formation annually.  Currently, cataract is the leading cause of blindness worldwide 
[1]. The etiology of cataract is diverse, however, aging is the most common risk factor for cataract 
formation [2]. This is supported by the notion that about 25% of the population over 65 and 50% of 
the population over 80 is affected [3]. Currently, the only available treatment for cataract is surgical 
intervention [4]. 
By definition, a cataract is an opacity of the lens of the eye. A lot of effort has been made to 
determine the etiology of cataracts, and several relevant mechanisms have been identified.  Lens 
proteins play a crucial role in maintaining the transparency of the lens. These proteins are extremely 
long-lived, as there is no protein synthesis and turnover in mature fiber cells. Consequently, age-
related modifications of these proteins accumulate over a lifetime that can result in the formation of 
insoluble protein aggregates, which are present in cataractous lenses [5-7].  
Lens epithelial cells (LECs) show phenotypic plasticity and therefore they can respond to 
environmental changes. For example, lens epithelial cells are able to undergo epithelial-to- 
mesenchymal transition (EMT) in response to injury or growth factors (e.g. transforming growth 
factor beta) [8]. LECs that undergo EMT show altered cell morphology, aberrant proliferation and 
migration properties, and are characterized by increased expression of extracellular matrix (ECM) 
proteins, intermediate filaments and various integrins as well as decreased expression of epithelial cell 
proteins [9]. EMT has been shown to play a major role in the formation of anterior subcapsular 
cataract, as well as in the opacification of intraocular lenses [10]. 
Determination of the chemical composition of senile cataractous lenses has revealed high 
concentrations of calcium (Ca) and phosphate, which form bone-like hydroxyapatite crystals [11-14]. 
Occasionally, calcification also occurs in young patients with congenital cataract or chronic uveitis 
[13, 15], while it can be a major complication of cataract surgery and play a role in the opacification of 
intraocular lenses [12, 16-18]. Although a cell-induced mechanism has been suggested in the 
background of lens calcification, no effort has been made to uncover more in depth this process [15, 
19]. 
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There is a remarkable overlap between the risk factors of cataract and vascular calcification, 
suggesting a common etiology of these diseases. Besides aging that largely contributes to both 
cataractogenesis and vascular calcification, diabetes and chronic kidney disease are also common 
predisposing factors for both diseases [20-23]. Nowadays, it is largely accepted that vascular 
calcification is a highly-regulated cell-mediated process, which involves osteo-/chondrogenic 
differentiation of vascular smooth muscle cells (VSMCs) [24-26]. Osteogenic triggers (e.g. inorganic 
phosphate (Pi), Ca, BMP-2 (bone-morphogenetic protein 2), glucose) initiate the osteo-/chondrogenic 
transition of VSMCs via the upregulation of osteo-/chondrogenic transcription factors, such as Runx2 
(Runt-Related Transcription Factor 2), Sox9 ((Sex Determining Region Y)-Box 9) and Msx2 (Msh 
Homeobox 2) [25, 27-30]. Furthermore, calcifying VSMCs express alkaline phosphatase (ALP), an 
early marker of osteogenesis, and osteocalcin (OCN), a major non-collagenous protein in the bone 
matrix that regulates mineralization [30].  
The aim of this study was to investigate whether human LECs (HuLECs) can undergo osteo-
/chondrogenic differentiation in vitro. We revealed that osteogenic stimuli induced osteo-
/chondrogenic phenotype transition of HuLECs via the upregulation of osteo-/chondrogenic 
transcription factors Runx2 and Sox9. Osteogenic stimuli upregulated ALP and OCN expressions and 
induced ECM mineralization. Furthermore, we observed that Ca accumulated in human cataractous 
lenses, when compared to non-cataractous control lenses, while some of the cataractous samples 
expressed the osteoblast-specific protein, OCN. We propose that osteo/chondrogenic differentiation of 
HuLECs might be involved in lens calcification.    
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2. MATERIALS AND METHODS 
2.1. Cell culture and reagents 
HuLECs were purchased from ScienCell Research Laboratories (San Diego, CA, USA). Cells were 
maintained in EpiCM supplemented with EpiCGS, 10% FBS, 10000 U/ml penicillin and 10000 μg/mL 
streptomycin (ScienceCell Research Laboratories). Cells were grown to confluence and used from 
passages 3 to 4. In certain experiments we used immortalized human lens epithelial cells (iHuLEC, 
CRL-11421) derived from ATCC (Manassas, VA, USA). Cells were cultured according to the 
manufacturer’s instructions. All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
unless otherwise specified.  
2.2. Human lens specimens 
Human cataractous lenses (n=10, M/F: 4/6, age: 71.5 ± 9.1) were collected from patients who had 
undergone cataract surgery (extracapsular cataract extraction)  at the Department of Ophtamology, 
Faculty of Medicine, University of Szeged after patient informed consent was obtained. All cataracts 
were senile type including 5 mixed nuclear and cortical cataracts, 2 nuclear cataracts and 3 
total/mature cataracts. Non-cataractous lenses (n=10, M/F: 3/7, age: 64.4 ± 11.5) were derived from 
human cadaver eyes removed within 24 hours of death at the Department of Pathology, Faculty of 
Medicine, University of Debrecen. All tissue collection complied with the Guidelines of the Helsinki 
Declaration and was approved by the Regional and Institutional Research Ethics Committee at the 
University of Debrecen, Hungary (DE OEC: 3094–2010). Lenses were snap-frozen in liquid nitrogen 
and stored at -70 °C until analysis. For Ca measurement, one-quarter of each lens was suspended in 
300 μl HCl (0.6 mol/L) for 1 hour at room temperature. Samples were centrifuged (2000 g, 5 min, RT) 
and supernatants were obtained. For OCN measurements, the remained three-quarters of each lens was 
suspended in 300 μl EDTA (0.5 mol/L, pH 6.9), frozen and thawed twice and sonicated (continuous 
mode, 30 sec); supernatants were collected after a brief centrifugation (2000 g, 5 min, 4°C). 
2.3. Induction of osteogenesis 
Osteogenic differentiation was induced as described previously [31]. Growth medium was 
supplemented with inorganic phosphate (NaH2PO4-Na2HPO4, pH 7.4) and CaCl2, as indicated on the 
individual graphs. Osteogenic medium was changed every other day. For time-course experiments, the 
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first day of culture in osteogenic medium was defined as Day 0. In some experiments we triggered 
osteogenic differentiation of HuLECs in the presence of phosphonoformic acid (PPFA, 1.5 mmol/L).   
2.4. Determination of cell viability 
Cell viability was determined by the MTT assay as previously described  [32]. Briefly, cells were 
cultured and treated in 96-well plates for the indicated time. Then cells were washed with PBS, and 
100 μL of 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (0.5 mg/mL) solution in 
HBSS was added. After a 4-hour incubation the MTT solution was removed, formazan crystals were 
dissolved in 100 μL of DMSO and optical density was measured at 570 nm.  
2.3. Alizarin Red staining 
After washing with PBS, the cells were fixed in 4% paraformaldehyde and rinsed with deionized water 
thoroughly. Cells were stained with Alizarin Red S solution (2%, pH 4.2) for 20 minutes at room 
temperature. Excessive dye was removed by several washes in deionized water. Extracellular Ca 
deposition was stained in red color using Alizarin Red S dye.  
2.4. Quantification of Ca deposition  
Cells grown in 96-well plates were washed twice with PBS and decalcified with 0.6 mol/L HCl for 30 
minutes. Ca content of the supernatants was determined by the QuantiChrome Calcium Assay Kit 
(Gentaur, Kampenhout Belgium) as previously described [33].  
2.5. Quantitative reverse transcription-polymerase chain reaction 
RNA was isolated from cells using Trizol (RNA-STAT60, Tel-Test Inc., Friendswood, TX, USA) 
according to the manufacturer’s protocol. Two micrograms of RNA were reverse transcribed to cDNA 
with High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Waltham, MA, USA). 
Quantitative real-time PCR was performed using iTaq Universal Probes Supermix (BioRad 
Laboratories, Hercules, CA, USA) and predesigned primers and probes (TaqMan® Gene Expression 
Assays) to detect Runx2 (Hs.535845), Sox9  (Hs.01001343), ALP (Hs.00768162), OCN 
(Hs.01587814), alpha smooth muscle actin (α-SMA, Hs.00426835), Slug (Hs.001619), E-cadherin 
(Hs.1023894), paired box protein 6 (Pax-6, Hs.00240871) and hypoxanthine-guanine phosphoribosyl 
transferase (HPRT, Hs.412707). Relative mRNA expressions were calculated with the ΔΔCt method 
using HPRT as internal control. 
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2.6. Western Blot analysis 
To evaluate Runx2, Sox9 and ALP protein expressions, cell lysates were run on 10% SDS-PAGE. 
Western
 
Blotting was performed with the use of a polyclonal anti-Runx2 antibody (Proteintech, 
Rosemont IL, USA) at 1:1000  dilution, anti-Sox9 antibody (Abcam, Cambridge, UK) at 1:1000  
dilution, a polyclonal anti-ALP antibody at 1:200 dilution (Santa Cruz Biotechnology Inc., Dallas, TX, 
USA), followed by HRP-labeled
 
anti rabbit IgG antibody (Amersham Biosciences Corp., Piscataway, 
NJ, USA). Antigen-antibody complexes were visualized with the horseradish peroxidase 
chemiluminescence system (Amersham Biosciences Corp., Piscataway, NJ, USA). After detection, the 
membranes were stripped and reprobed for GAPDH using anti-GAPDH antibody at a dilution of 
1:1000 (Novus Biologicals, Littleton, CO, USA). Results were quantified by using Alpha DigiDoc RT 
(Alpha Innotech, San Leandro, CA, USA) quantification system. 
2.7. Quantification of OCN 
For OCN detection, the ECM of cells grown on 6-well plates was dissolved in 100 µL of EDTA (0.5 
mol/L, pH 6.9). OCN content of the EDTA-solubilized ECM samples was quantified by an enzyme-
linked immunosorbent assay (ELISA) (eBioscience, San Diego, CA, USA). 
2.8. Phosphate measurement 
After a 24-hour treatment, cells were washed twice with PBS and solubilized in a lysis buffer 
containing 10 mmol/L TrisHCl, 5 mmol/L EDTA, 150 mmol/L NaCl (pH 7.2), 1% Triton X-100, 
0.5% Nonidet P-40 and protease inhibitors (Complete Mini, F. Hoffmann-La Roche Ltd., Basel, 
Switzerland). Phosphate levels of cell lysates were determined by the QuantiChrome phosphate Assay 
Kit (Gentaur, Kampenhout Belgium).  
2.9. Statistical analysis 
Data are shown as mean ± SD. Statistical analysis was performed by ANOVA test followed by post 
hoc Newmann-Keuls test for multiple comparisons. A value of p < 0.05 was considered significant. 
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3. RESULTS 
3.1. Osteogenic stimuli induce ECM mineralization of HuLECs in a cell-mediated manner without 
affecting cell viability 
Elevated levels of phosphate and Ca are well-characterized and pathophysiologically relevant triggers 
of VSMC mineralization and osteogenic differentiation. To determine whether osteogenic stimuli 
induce ECM mineralization in HuLECs, cells were cultured in calcification medium which was 
prepared by addition of Pi and Ca at the indicated concentrations (0-3.5 mmol/L and 0-1.2 mmol/L, 
respectively) to the growth medium. Granular deposits developed in HuLECs in a dose-dependent 
manner in 7 days, but not in the control cells (cultured in growth medium without  Pi or Ca addition) 
as demonstrated by Alizarin Red staining (Fig 1A). Pi alone induced ECM mineralization of HuLECs 
at the dose of 3.5 mmol/L, whereas Ca alone could not trigger matrix mineralization. Ca synergized 
Pi-induced mineralization at each tested concentrations. To quantify the extent of matrix 
mineralization we measured Ca content of the ECM after culturing the cells for 7 days under 
osteogenic conditions. We found that Pi and Ca synergistically increased the Ca content of the ECM in 
HuLECs (Fig. 1B).  
We made a time course experiment to demonstrate that calcification is an active cell-mediated 
process and not passive precipitation of hydroxyapatit. In this experiment we treated living or PFA-
fixed HuLECs with osteogenic medium (addition of 2.5 mmol/L Pi and 1.2 mmol/L Ca to the growth 
medium). We determined the amount of Ca deposition on Day 0, 3, 5 and 7 (Fig. 1C). Ca deposition 
started on Day 5 in the living cell-containing wells and increased further until Day 7 (Fig. 1C). In 
contrast, we did not observe ECM mineralization in PFA-fixed cells (Fig. 1C).  
Apoptotic cell death has been reported during calcification and matrix mineralization of 
VSMCs [34], therefore we examined whether matrix mineralization of HuLECs is associated with cell 
death. We cultured HuLECs in osteogenic medium for 7 days, and then we assessed cell viability by 
MTT assay. In contrast to VSMCs, we observed that osteogenic stimuli did not induce cell death in 
HuLECs (Fig. 1D). Overall, these results suggest that Pi-mediated HuLEC mineralization is a cell-
mediated active process, in which cell death does not play a role.    
3.2. Pi uptake is critically involved in osteogenic stimuli-triggered calcification of ECM in HuLECs 
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Active transport of phosphate into the cells via type III sodium-dependent phosphate cotransporters is 
absolutely required for phosphate-induced osteogenic differentiation and calcification of VSMCs [35]. 
Phosphate treatment increases intracellular phosphate levels in VSMCs [31], and inhibition of 
phosphate transport by PPFA prevents calcification of VSMCs [36] therefore next we asked whether 
the same occurs in HuLECs. We found that a 24-hour phosphate treatment dose-dependently increased 
intracellular phosphate levels in HuLECs, which increase was completely abolished in the presence of 
PPFA  (Fig. 2A), suggesting that active phosphate transport takes place in these cells, similarly to 
VSMCs. Then we investigated whether inhibition of phosphate uptake influence mineralization of 
HuLECs. We treated HuLECs with osteogenic medium (0.6 mmol/L Ca, 0; 2.5; 3.0; 3.5 mmol/L Pi) in 
the presence or absence of PPFA for 7 days and accessed ECM mineralization by Alizarin Red 
staining. As shown by Fig 2B, PPFA completely inhibited ECM mineralization in HuLECs. 
Quantification of the Ca content of ECM supported the results obtained by Alizarin Red staining (Fig. 
2C).  We concluded that active transport of phosphate is critical in phosphate-triggered ECM 
mineralization in HuLECs.  
3.3. HuLECs mineralization is accompanied by upregulation of osteo-/chondrogenic transcription 
factors: Runx2 and Sox9  
VSMC differentiation to an osteogenic phenotype, which is characterized by elevated levels of 
osteogenic and/or chondorgenic transcription factors, has been identified as the underlying mechanism 
of vascular calcification [30, 37]. Therefore we assessed the expression of the key osteogenic 
transcription factor, Runx2, and the master regulator of chondrogenesis, Sox9, to examine whether 
osteogenic differentiation occurs in HuLECs upon osteogenic stimuli. We exposed HuLECs to 
osteogenic medium (2.5 mmol/L Pi, 1.2 mmol/L Ca) for 24 hours then measured mRNA levels of 
Runx2 and Sox9. The osteogenic stimuli almost doubled the Runx2 and Sox9 mRNA levels in 
HuLECs compared to control cells (Fig. 3A and B). Western blot analysis confirmed the gene 
expression results and revealed that the osteogenic stimuli can trigger a 1.9-fold increase in Runx2 
(Fig. 3C and E) and a 5.5-fold elevation in Sox9 (Fig 3D and F) protein expressions. These results 
suggest that Pi and Ca induce osteo-/chondrogenic differentiation of HuLECs. 
3.4. ALP and OCN are upregulated in mineralizing HuLECs  
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ALP, being a phosphohydrolytic enzyme plays an important role in bone mineralization as well as in 
pathological mineralization in non-osteogenic tissues [38]. First we determined ALP mRNA levels at 
basal (control) and calcifying conditions (Pi/Ca) in HuLECs (Fig. 4A). Osteogenic treatment (7 days, 
2.5 mmol/L Pi and 1.2 mmol/L Ca) resulted in a ~ 1.7-fold increase in ALP mRNA (Fig. 4A). This 
increase in ALP mRNA level was associated with increased protein expression of ALP (Fig. 4B). Both 
Pi (3 mmol/L) and Ca (1.2 mmol/L), when applied separately, triggered a mild (~ 1.7-fold) increase in 
ALP expression in HuLECs (Fig. 4B and C). When Pi (2 mmol/L) and Ca (1.2 mmol/L) were applied 
together, we obtained a 3-fold increase in ALP expression, whereas 3 mmol/L Pi together with 1.2 
mmol/L Ca resulted in a 4.1-fold increase in ALP level (Fig. 4B and C). These results suggest that Pi 
and Ca act in a synergistic manner in increasing ALP expression in HuLECs (Fig. 4B and C). Lastly, 
we assessed ALP activity, and found that both Pi (3 mmol/L) and Ca (1.2 mmol/L) caused a mild 
elevation in ALP activity when applied separately, and they acted in a synergistic way to further 
increase ALP activity, when applied together (Fig. 4D).  
OCN, being a major non-collagenous protein of fully mineralized bone-matrix, is highly 
expressed in calcifying VSMCs [37, 39]. Therefore next we checked whether OCN gets also 
upregulated in HuLECs under osteogenic stimulation. We cultured HuLECs under control, and 
calcifying conditions (Pi/Ca) for 7 days, and measured OCN mRNA levels. Osteogenic stimuli 
induced a more than 2-fold elevation in OCN mRNA levels (Fig. 5A). Then the OCN content of the 
ECM of HuLECs cultured in the presence or absence of Pi and Ca for 7 days was analyzed by ELISA. 
No OCN could be detected in the EDTA-solubilized ECM of HuLECs cultured under basal conditions 
(without Pi or Ca supplementation) (Fig. 5B). Supplementation of the growth medium with Pi (3 
mmol/L) or Ca (1.2 mmol/L) caused a minor increase in OCN levels resulting 0.156 ng/ml and 1.027 
ng/ml OCN respectively (Fig. 5B). Importantly, when Pi and Ca were applied together, a marked 
elevation in OCN levels was observed in the ECM of HuLECs (Fig. 5B). These findings further 
support our notion that Pi and Ca trigger osteogenic differentiation of HuLECs in a synergistic 
manner.  
3.5. Osteogenic differentiation of HuLECs shares some similarities with EMT 
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Certain stimuli can induce EMT in lens epithelial cells. To see whether HuLECs are undergo EMT 
upon osteogenic stimulation, we treated the cells with osteogenic medium (Pi: 2.5 mmol/L, Ca: 1.2 
mmol/L) and measured mRNA levels of α-SMA, Slug, Pax-6 and E-cadherin on Day 1 and Day 5. We 
found that osteogenic stimulation decreased α-SMA, and E-cadherin mRNA levels (Fig. 6 A and D). 
Expression of Slug mRNA increased in a time-dependent manner, reaching about 2.5-fold elevation on 
Day 5 (Fig. 6B). We observed a slight decrease in Pax-6 mRNA level on Day1 which was normalized 
by Day 5 (Fig. 5C). We concluded that osteogenic differentiation shares some similarities with EMT.    
3.6. Osteogenic stimuli induce osteogenic differentiation and ECM mineralization in iHuLECs 
Because we performed all of the differentiation experiments with the use of primary cells derived from 
one particular donor, we wanted to see whether well-characterized lens epithelial cells behave a 
similar manner regarding osteogenic differentiation. Therefore we exposed iHuLEC to calcification 
medium which was prepared by addition of Pi and Ca at the indicated concentrations (0-3.5 mmol/L 
and 0-1.2 mmol/L, respectively) to the growth medium. ECM mineralization was assessed by Alizarin 
Red staining (Fig. 6A) on Day 7. Pi and Ca triggered ECM mineralization of iHuLEC cells similarly 
to that of primary HuLEC cells. We quantified the extent of matrix mineralization by measuring Ca 
content of the ECM after culturing the cells for 7 days under osteogenic conditions. As shown in Fig. 
6B, Pi and Ca synergistically increased Ca content of the ECM in iHuLECs. We addressed whether 
osteogenic stimulation increases the expression of the osteogenic transcription factor Runx2, and its 
target protein OCN. We exposed HuLECs to osteogenic medium (2.5 mmol/L Pi, 1.2 mmol/L Ca) for 
24 hours then measured mRNA levels of Runx2 and OCN. Osteogenic stimuli triggered a 3.5 ± 0.6-
fold increase in Runx2 and a 1.8 ± 0.1-fold elevation in OCN mRNA levels in iHuLECs compared to 
controls (Fig. 6C and D). 
3.7. Presence of Ca and OCN in human cataractous lenses  
We aimed to explore whether osteogenic differentiation of HuLECs plays a role in human cataract 
formation. We analyzed Ca and OCN content of human non-cataractous lenses (n=10) derived from 
cadaver human eyes and cataractous lenses (n=10) collected from patients who had undergone cataract 
surgery. The Ca content of cataractous lenses was significantly higher than that of control lenses 
(0.123 ± 0.097 vs. 0.019 ± 0.016 μg Ca/mg tissue) (Fig. 6). OCN was non-detectable in non-
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cataractous lenses. In contrast, we found low but measurable amounts of OCN in 2 out of the 10 
cataractous lenses (0.52 ng/ml and 0.69 ng/ml). Interestingly, OCN positivity was associated with the 
highest Ca levels (above 0.25 μg Ca/mg tissue). These results suggest that osteogenic differentiation 
might play a role in lens calcification in vivo.  
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4. DISCUSSION 
In this study we examined the process of osteo-/chondrogenic differentiation of HuLECs in vitro and 
the potential involvement of this differentiation process in lens calcification. Osteo-/chondrogenic 
differentiation is essential for the growth, repair and remodeling of bone and cartilage tissues, 
therefore it has an important physiologic role. On the other hand, pathological osteo-/chondrogenic 
differentiation is involved in ectopic calcification, when precipitation and deposition of Ca-phosphate 
salts occurs in the form of hydroxyapatite in extra-skeletal soft tissues. Although ectopic calcification 
has long been considered as a passive and degenerative process, nowadays it is recognized as a cell-
mediated, highly regulated pathway, which shares many features with bone formation. The most 
frequently seen and the most studied form of ectopic calcification is vascular calcification, in which a 
subpopulation of vascular cells, called calcifying vascular cells, undergo osteogenic differentiation in 
response to an osteogenic stimuli [40]. These osteoprogenitor cells in the vasculature can derive from 
different cell types including mesenchymal stem cells, monocytes, pericytes and VSMCs [41].   
Both vascular calcification and cataract formation are strongly associated with aging, diabetes 
and chronic kidney disease [20-23]. Moreover, recent studies revealed that mutations of certain genes 
lead to the appearance of cataract and diverse types of ectopic calcification. For example, a 
homozygous mutation in the lamin A/C gene has been described in a 44-year-old patient, who suffered 
from tendon calcification and cataract [42].  Activating mutation of the Ca-sensing receptor was also 
found to be associated with cataract formation and ectopic calcification in a mouse model [43]. 
Additionally, cataract and calcification of the basal ganglia has been described in a patient who 
suffered from progeroid syndrome - a rare genetic disorder that mimics physiological aging, making 
the affected individuals appear older than what they are [44]. Furthermore, in a recent study of 6 
patients suffering from Cockayne syndrome, the co-presence of intracranial calcification and cataract, 
was reported [45]. These results suggest that ectopic calcification and cataract might have common 
etiological factors.  
Osteo-/chondrogenic differentiation of VSMCs is one of the critical cellular events in vascular 
calcification. It is long recognized that disturbances of the phosphate and Ca metabolism, that results 
hypercalcemia and hyperphosphatemia, play a major role in vascular and other soft tissue calcification 
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in patients with chronic kidney disease [46]. In parallel with the clinical findings, elevated Pi and Ca 
induce osteogenic differentiation and ECM mineralization of VSMCs in vitro [27]. Pi-induced 
mineralization of VSMCs became an important model to study the mechanism of vascular 
calcification. We used this model, and stimulated HuLECs with Pi and Ca, to test whether osteo-
/chondorogenic differentiation and ECM mineralization can be triggered in these cells in vitro. We 
found that elevated Pi induces matrix mineralization of HuLECs, and Ca synergizes the effect of Pi.  
Although there is a case report suggesting a pathological role of elevated Pi in cataract 
formation [47], it is an open question whether elevated Pi and Ca levels could be clinically relevant in 
lens calcification. Lens is avascular tissue nurtured by aqueous humor.  There is a single article in 
which the authors investigated Ca and Pi content of aqueous humor in cataract patients [48]. 
According to that study Ca concentration of aqueous humor is 5.74 mg/dL, and the Pi is 2.19 mg/dL in 
non-diabetic subjects with cataract. The osteogenic medium we used to trigger osteogenic 
differentiation of HuLECs contained twice as much Ca and five-times more Pi than the aqueous 
humor of cataract patient, but we assume that osteogenic differentiation of HuLECs is a multifactorial 
process in vivo. Imbalance of calcification inducers and inhibitors is behind vascular calcification. 
Presumably that could be the case in lens calcification in which different inducers – not yet 
characterized – could act in a synergistic manner to induce osteogenic differentiation of lens cells. 
What regards calcification inhibitors, mass spectrometry analysis revealed the presence of alpha-2-HS-
glycoprotein (fetuin-A), the well-known inhibitor of vascular calcification, in aqueous humor [49]. 
Further work needs to be done to identify the clinically relevant inducers and inhibitors of lens 
calcification.  
Phosphate-induced osteogenic differentiation and calcification of VSMCs require active 
transport of extracellular phosphate into the cells [36] that is accomplished by type III sodium-
dependent phosphate cotransporters PiT-1 and PiT-2 [35]. Recently, the critical involvement of PiT-1 
in chondrogenesis has been demonstrated as well [50]. Currently, we lack information about 
phosphate handling of HuLECs and the expression of such type III sodium-dependent phosphate 
cotransporters. Nevertheless, we showed that phosphate treatment increased intracellular phosphate 
levels in HuLECs, similarly to that of VSMCs, which suggests the presence of active phosphate 
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transport in lens epithelia. Moreover, we found that inhibition of phosphate uptake by PPFA results in 
diminished mineralization of ECM. Considering the critical involvement of phosphate uptake in the 
process of ECM mineralization, further research needs to be done to identify the transporter(s) 
involved in phosphate uptake and subsequent mineralization of LECs. 
Runx2 and Sox9, the key transcription factors regulating osteoblastogenesis and 
chondrogenesis, respectively, play a role in vascular calcification as well.  This notion is strongly 
supported by the observation that these osteo-/chondrogenic transcription factors are highly expressed 
in calcified human arterial samples compared to noncalcified vessels [30].  Furthermore, in vitro 
studies revealed that Runx2 and Sox9 are upregulated upon osteo-/chondrogenic transition of VSMCs 
[25, 51, 52]. Here, we showed that HuLECs express both Runx2 and Sox9 under basal conditions. 
Production of Runx2 and/or Sox9 is not a unique feature of LECs, as epithelial cells of different origin 
such as amniotic, proximal tubular, dental and mammary epithelial cells also express Runx2 and/or 
Sox9 [53-57]. Elevated expressions of Runx2 and/or Sox9 in these epithelial cells of diverse origin 
have been linked to a stem-cell like phenotype with osteogenic differentiation and/or regenerative 
potentials [53-57]. The osteogenic stimuli implemented in the present study upregulated the Runx2 
and Sox9 expression, suggesting that osteo-/chondrogenic differentiation of HuLECs occurs in vitro.    
 Tissue-nonspecific ALP enzymes (TNAP) are ubiquitously expressed in all tissues, with the 
highest production in liver, kidney and bone. TNAP plays a critical role in bone mineralization, as 
well as in ectopic calcification [38]. The effect of TNAP relies on its ability to hydrolyze extracellular 
pyrophosphate, a potent inhibitor of hydroxyapatite formation [58]. Overexpression of TNAP in 
VSMCs in mice results in extensive vascular calcification, high blood pressure, cardiac hypertrophy, 
and early death, whereas pharmacological inhibition of TNAP activity reverses these deleterious 
effects [59]. Interestingly, ALP activity is significantly elevated in the plasma of cataract patients [60]. 
Since increased ALP has been associated with elevated -glutamyl transferase level, it was suggested 
that subclinical liver dysfunction is a risk factor for cataract formation [60], but this idea was not 
strengthened by further studies. Besides hepatobiliary disorders, elevation of ALP is also detected  in 
bone diseases associated with increased osteoblastic activity and bone remodeling, such as Paget's 
disease, hyperparathyroidism, rickets and osteomalacia, fractures, and malignant tumors. Accelerated 
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bone growth in children and juveniles can also cause a rise in ALP activity. In vitro studies revealed 
that ALP expression and activity are highly elevated in calcifying VSMCs [61]. Similarly to that of 
VSMCs, we observed that mineralization of HuLECs is accompanied by increased expression and 
enzymatic activity of ALP. Further studies are needed to explore whether vascular calcification or 
other types of ectopic calcification are associated with systemic elevation of ALP activity. 
OCN is highly expressed in the fully mineralized bone-matrix, cartilage and dental tissues. Besides its 
long-known function of binding hydroxyapatite in osteochondral tissues, OCN is currently considered 
as a regulatory molecule of mineralization and a marker of bone metabolism. Recent findings also 
highlighted new extra-skeletal roles for OCN, in which OCN acts as a hormone [62]. High OCN 
expressions have been found in mineralized extra-skeletal tissues such as calcified vessels and skin 
lesions in patients with calcific uremic arteriolopathy [30, 63]. Recently, a correlation between 
calcifying OCN‐positive endothelial progenitor cells and spotty calcification in patients with coronary 
artery disease was described [64]. These data suggest that OCN plays a role in ectopic calcification. 
Under in vitro conditions calcifying VSMCs highly express OCN [37, 39], and here we revealed that 
osteogenic stimuli upregulate OCN expression in HuLECs as well. Importantly, we showed that OCN 
is expressed in some human cataractous lenses, but not in control lenses. Overall, our findings strongly 
suggest that osteogenic stimuli represented by elevated Pi and Ca induce osteo-/chondrogenic 
differentiation of HuLECs with the critical involvement of phosphate uptake via the upregulation of 
osteo-/chondrogenic transcription factors Runx2 and Sox9. The resulting osteoblast-like cells express 
osteoblast-specific proteins, such as ALP and OCN and exhibit ECM mineralization.  We propose that 
this mechanism might contribute to lens calcification, which is supported by our finding that some 
human cataractous lenses express the osteoblast-specific protein, OCN. 
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7. FIGURE LEGENDS 
Figure 1 
Osteogenic stimuli induce matrix mineralization and Ca deposition of HuLECs in a cell-mediated 
manner, without affecting cell viability  
(A, B and D) HuLECs were cultured in growth medium supplemented with Pi (0-3.5 mmol/L) and Ca 
(0-1.2 mmol/L) as indicated for 7 days. (A) Ca deposition as a readout of ECM mineralization was 
visualized by Alizarin Red staining. Representative image of stained plates from three independent 
experiments is shown. (B) Ca content of the HCl-solubilized ECM is presented. Data are expressed as 
mean ± SD of three independent experiments performed in quadruplicates. (C) Living (closed circles) 
or PFA-fixed HuLECs (open circles) were treated with osteogenic medium (2.5 mmol/L Pi and 1.2 
mmol/L Ca). ECM Ca content was determined on Day 0, 3, 5 and 7. Results are presented as mean ± 
SD of two independent experiments performed in quadruplicates. (D) After 7 days of treatment with 
osteogenic medium cell viability was determined by MTT assay. Data are expressed as mean ± SD of 
three independent experiments performed in quadruplicates.
*
p < 0.05, 
**
p < 0.01, 
***
p < 0.005 
Figure 2  
Pi uptake is critically involved in osteogenic stimuli-triggered calcification of ECM in HuLECs 
 (A-C) HuLECs were cultured in growth medium or osteogenic medium supplemented with Pi (2.5, 
3.0, 3.5 mmol/L) and Ca (0.6 mmol/L) in the presence or absence of PPFA (1.5 mmol/L). (A) After a 
24-hour treatment intracellular Pi levels were determined from the cell lysates. Results are presented 
as mean ± SD of three independent experiments performed in triplicates. (B) Ca deposition as a 
readout of ECM mineralization was visualized by Alizarin Red staining on Day 7. Representative 
image of stained plates from two independent experiments is shown. (C) Ca content of the HCl-
solubilized ECM was measured on Day 7. Data are expressed as mean ± SD of two independent 
experiments performed in quadruplicates. ***p < 0.005 
Figure 3 
Osteogenic stimuli trigger upregulation of osteo-/chondrogenic transcription factors: Runx2 and Sox9  
(A-F) HuLECs were cultured in growth medium or osteogenic medium (supplemented with 2.5 
mmol/L Pi and 1.2 mmol/L Ca) for 24 hours. (A and B) Relative expressions of Runx2 and Sox9 
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normalized to HPRT are presented. Results are presented as mean ± SD of three independent 
experiments performed in triplicates. (C and D) Representative Western blots from three independent 
experiments are shown. (E and F) Relative expressions of Runx2 and Sox9 normalized to GAPDH 
were determined by densitometric analysis. Graph shows mean ± SD of three separate experiments. **p 
< 0.01, 
***
p < 0.005 
Figure 4 
Osteogenic stimuli increase ALP mRNA levels, protein expression and activity in HuLECs 
(A) HuLECs were cultured in growth medium or osteogenic medium (supplemented with 2.5 mmol/L 
Pi and 1.2 mmol/L Ca) for 7 days. Relative mRNA level of ALP normalized to HPRT was determined 
by quantitative RT-PCR. Results are expressed as mean ± SD of three independent experiments 
performed in triplicates. (B-D) HuLECs were cultured in growth medium or osteogenic medium 
(supplemented with Pi and Ca as indicated) for 7 days and lysed. (B) Representative Western blots 
showing ALP and GAPDH expressions from three independent experiments are presented. (C) 
Relative expressions of ALP normalized to GAPDH were determined by densitometric analysis.  
Graph shows mean ± SD of three independent experiments. (D) ALP activities were determined from 
cell lysates and expressed as fold increase compared to control cells. Results are expressed as mean ± 
SD of three independent experiments performed in triplicates. 
*
p < 0.05, 
**
p < 0.01, 
***
p < 0.005 
Figure 5 
Osteogenic stimuli increase OCN mRNA and protein expressions in HuLECs 
(A) HuLECs were cultured in growth medium or osteogenic medium (supplemented with 2.5 mmol/L 
Pi and 1.2 mmol/L Ca) for 7 days. Relative mRNA level of OCN normalized to HPRT was determined 
by quantitative RT-PCR. Results are expressed as mean ± SD of three independent experiments 
performed in triplicates. (B) HuLECs were cultured in growth medium or osteogenic medium 
(supplemented with Pi and Ca, as indicated) for 7 days. ECM was solubilized in EDTA and OCN was 
determined by ELISA. Results are expressed as mean ± SD of three independent experiments 
performed in duplicates. 
***
p < 0.005 
Figure 6.  
Effect of osteogenic stimuli on markers of EMT  
23 
 
(A-D) HuLECs were cultured in osteogenic medium (supplemented with 2.5 mmol/L Pi and 1.2 
mmol/L Ca) for 1 or 5 days. Relative mRNA levels of α-SMA, Slug, Pax-6 and E-cadherin normalized 
to HPRT were determined by quantitative RT-PCR and expressed as % of non-stimulated controls.  
Results are presented as mean ± SD of two independent experiments performed in triplicates. *p < 
0.05, 
**
p < 0.01, 
***
p < 0.005 
Figure 7 
Osteogenic stimuli induce ECM mineralization and osteogenic differentiation of iHuLECs  
(A-B) iHuLECs were cultured in growth medium supplemented with Pi (0-3.5 mmol/L) and Ca (0-1.2 
mmol/L) as indicated for 7 days. (A) Representative Alizarin Red staining from two independent 
experiments is shown. (B) Ca content of the HCl-solubilized ECM is presented. Data are expressed as 
mean ± SD of two independent experiments performed in triplicates. (C-D) iHuLECs were exposed to 
osteogenic medium (2.5 mmol/L Pi and 1.2 mmol/L Ca) for 24 hours. Relative mRNA levels of Runx2 
and OCN normalized to HPRT were determined by quantitative RT-PCR. Results are expressed as 
mean ± SD of three independent experiments performed in triplicates.*p < 0.05, **p < 0.01, ***p < 
0.005 
Figure 8 
Ca concentration is increased in human cataractous lenses 
Ca levels were determined from human cataractous (n=10) and control (n=10) lenses. Results are 
expressed as g/mg wet tissue.  
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8. ABBREVIATIONS 
ALP: alkaline phosphatase 
α-SMA: alpha-smooth muscle actin 
BMP-2: bone-morphogenetic protein 2 
Ca: calcium 
ECM: extracellular matrix 
ELISA: enzyme-linked immunosorbent assay 
EMT: epithelial-to- mesenchymal transition 
HPRT: hypoxanthine-guanine phosphoribosyl transferase 
HuLECs: human lens epithelial cells 
iHuLEC: immortalized human lens epithelial cells 
LEC: lens epithelial cells 
Msx2: Msh Homeobox 2 
OCN: osteocalcin 
Pax-6: paired box protein 
Pi: inorganic phosphate 
PFA: paraformaldehyde 
PPFA: phosphonoformic acid 
Runx2: Runt-Related Transcription Factor 2 
Sox9: (Sex Determining Region Y)-Box 9 
TNAP: tissue-nonspecific alkaline phosphatase 
VSMCs: vascular smooth muscle cells 
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